Show simple item record

dc.contributor.authorHogan, Andrew
dc.date.accessioned2013-08-07T10:27:47Z
dc.date.available2013-08-07T10:27:47Z
dc.date.issued2012-06
dc.identifier.urihttp://hdl.handle.net/10147/297475
dc.description.abstractAmerican Diabetes Association Annual Meeting in Philadelphia in June 2012
dc.language.isoenen
dc.subjectDIABETES MELLITUS
dc.titleGlucagon-like peptide-1 (GLP-1) - a key regulator of innate immune function with clinical efficacy in a range of inflammatory diseasesen_GB
dc.typeConference Presentationen
dc.description.fundingNo fundingen
dc.description.linkhttp://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=b2037368-6e8e-4a56-ab42-b8c9ff38e7c3&cKey=2cfd5cf3-dc1a-4269-89d7-6038cd508f21&mKey={0F70410F-8DF3-49F5-A63D-3165359F5371}
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
html.description.abstractAmerican Diabetes Association Annual Meeting in Philadelphia in June 2012


This item appears in the following Collection(s)

Show simple item record